This activity is directed toward pharmacists who are involved in the management of patients with solid tumors.
Empowering Community Pharmacists as Health Consultants: Polypharmacy
Available for Credit: May 15, 2015 - May 31, 2016
This activity has been designed to meet the educational needs of community clinical and retail pharmacists.
Empowering Community Pharmacists as Health Consultants: Asthma
Available for Credit: May 5, 2015 - May 31, 2016
This activity has been designed to meet the educational needs of community clinical and retail pharmacists.
Empowering Community Pharmacists as Health Consultants: Noncancer Pain
Available for Credit: March 31, 2015 - March 31, 2016
This activity has been designed to meet the educational needs of community clinical and retail pharmacists.
This activity is directed toward medical and surgical oncologists, dermatologists, and radiation oncologists involved in the treatment of patients with cutaneous malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of cutaneous malignancies are also invited to participate.
Empowering Community Pharmacists as Health Consultants: Irritable Bowel Syndrome
Available for Credit: February 20, 2015 - February 28, 2016
This activity has been designed to meet the educational needs of community clinical and retail pharmacists.
Precision Medicine and Big Data in Multiple Myeloma
Available for Credit: February 6, 2015 - February 6, 2016
This activity is directed toward oncologists and hematologists, advanced practice oncology nurses, research nurses, and clinical oncology pharmacists and other stakeholders on the healthcare team involved in the management of patients with multiple myeloma (MM).
This activity is directed toward medical oncologists and hematologists, pathologists, geneticists, and other healthcare providers, including advanced practice oncology/hematology nurses, research nurses, clinical oncology pharmacists, and genetic counselors involved in the management of patients with solid cancers or hematologic malignancies, and interested in the use of molecular biomarkers to help optimize patient care.
This activity is directed toward pharmacists who are involved in the management of patients with schizophrenia.
Faculty Perspectives: Latest Treatment Advances for Individualized Care of CRC
Available for Credit: January 22, 2015 - January 22, 2016
This activity is directed toward medical and surgical oncologists, advanced practice oncology nurses, research nurses, and clinical oncology pharmacists involved in the personalized management of patients with solid tumors, and interested in the use of molecular biomarkers to help optimize patient care.
Page 1 of 3
Results 1 - 10 of 22